- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sirolimus; Orthotopic liver transplantation; HCC
Total 18526 results
-
Newish Technology (Beijing) Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesRecruitingHepatocellular CarcinomaChina
-
Zhongda HospitalRecruiting
-
Johns Hopkins UniversityKing Faisal Specialist Hospital and Research Center in Riyadh (Saudi Arabia) and other collaboratorsRecruitingLiver Cirrhosis | Hepatocellular Carcinoma | Liver Cancer | Early Stage Liver CancerSaudi Arabia, Vietnam
-
Peking Union Medical College HospitalRecruitingHepatocellular CarcinomaChina
-
RenJi HospitalNot yet recruitingHepatocellular Carcinoma | Liver Transplant; Complications | Liver Cancer | Portal Vein Thrombosis | Radiotherapy; ComplicationsChina
-
Bristol-Myers SquibbRecruitingCarcinoma, HepatocellularUnited States, Taiwan, Spain, France, Korea, Republic of, Germany, Puerto Rico, China, Japan, Canada, Hong Kong, Australia, Poland, Singapore, Italy
-
Zhongda HospitalRecruitingHepatocellular CarcinomaChina
-
Zhongda HospitalRecruitingHepatocellular CarcinomaChina
-
AkesoRecruitingUnresectable, Non-metastatic Hepatocellular CarcinomaChina
-
Fudan UniversityRecruiting
-
Zhejiang UniversityNot yet recruitingHepatocellular CarcinomaChina
-
AstraZenecaRecruitingHepatocellular CarcinomaSpain, Canada, Germany, Belgium, United States, France, Italy, Japan, China, Egypt, Russian Federation, Taiwan, Vietnam, Thailand, Saudi Arabia, Portugal, India, Korea, Republic of, Brazil, Malaysia, Mexico, Philippines, Puerto Rico
-
Shanghai Henlius BiotechNot yet recruitingAdvanced Hepatocellular Carcinoma
-
National Taiwan University HospitalNot yet recruitingUnresectable Hepatocellular Carcinoma | Pembrolizumab | Stereotactic Body Radiotherapy | LenvatinibTaiwan
-
Zhongnan HospitalRecruitingHepatocellular Carcinoma; Targeted Therapy; Progression-free SurvivalChina
-
Zhongda HospitalRecruiting
-
University of LiegeUniversitaire Ziekenhuizen KU Leuven; University Hospital, Ghent; University... and other collaboratorsRecruitingHepatocellular CarcinomaBelgium
-
Second Affiliated Hospital of Guangzhou Medical...First Affiliated Hospital, Sun Yat-Sen University; First People's Hospital... and other collaboratorsRecruiting
-
TaiRx, Inc.RecruitingHepatocellular Carcinoma | Advanced CancerTaiwan
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingHepatocellular CarcinomaChina
-
The Second Affiliated Hospital of Chongqing Medical...Cellomics International LimitedRecruitingHepatocellular Carcinoma | Circulating Tumor Cell | Whole Genome SequencingChina
-
The Central Hospital of Lishui CityNot yet recruiting
-
Chinese PLA General HospitalImmunotech Applied Science Ltd.RecruitingHepatocellular Carcinoma (HCC)China
-
Shanghai Zhongshan HospitalRecruitingA Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCCHepatocellular Carcinoma | DonafenibChina
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; University of Leeds and other collaboratorsRecruitingHepatocellular CarcinomaDenmark
-
Can-Fite BioPharmaRecruitingHepatocellular Carcinoma | CirrhosisUnited States, Bosnia and Herzegovina, Bulgaria, Israel, Moldova, Republic of, Poland, Romania, Serbia, Slovakia
-
Sun Yat-sen UniversityRecruitingHepatocellular CarcinomaChina
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingUnresectable Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC v8 | BCLC Stage B Hepatocellular Carcinoma and other conditionsUnited States
-
Helio GenomicsRecruitingLiver Cirrhosis | HCC | Hepatocellular Carcinoma | Liver CancerUnited States
-
CHA UniversityRecruitingHepatocellular CarcinomaKorea, Republic of
-
Lion TCR Pte. Ltd.Not yet recruitingHepatocellular Carcinoma | Liver Cell Carcinoma | Liver Cancer, Adult
-
University College, LondonMerck Sharp & Dohme LLCRecruitingHepatocellular CarcinomaUnited Kingdom
-
CHA UniversityBoryung Pharmaceutical Co., LtdRecruitingAdvanced Hepatocellular CarcinomaKorea, Republic of
-
Peking UniversityRecruitingHepatocellular CarcinomaChina
-
Nanfang Hospital of Southern Medical UniversityRecruitingHepatocellular CarcinomaChina
-
Peking UniversityRecruitingHepatocellular Carcinoma | Portal Vein ThrombosisChina
-
Second Affiliated Hospital of Guangzhou Medical...Recruiting
-
National Cancer Centre, SingaporeNanyang Technological University; Duke-NUS Graduate Medical School; MiRXES Pte... and other collaboratorsRecruitingHepatocellular CarcinomaSingapore
-
Ontario Clinical Oncology Group (OCOG)Hoffmann-La RocheRecruitingHepatocellular Carcinoma | Portal Vein Tumour ThrombosisCanada
-
University Hospital, GrenobleUniversity Hospital, Caen; National Cancer Institute, France; Amiens University... and other collaboratorsRecruitingHepatocellular CarcinomaFrance
-
Shanghai Zhongshan HospitalNot yet recruitingHepatocellular Carcinoma Stage III
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingHepatocellular Carcinoma | Cirrhosis | Liver Cancer | Chronic Liver DiseaseFrance
-
Massachusetts General HospitalGenentech, Inc.Not yet recruitingUnresectable Hepatocellular CarcinomaUnited States
-
Beijing Friendship HospitalNot yet recruitingLiver Cirrhosis | Hepatitis B
-
Alexandria UniversityRecruitingLiver Cirrhosis | Hepatocellular Carcinoma | Diagnoses DiseaseEgypt
-
Next Biomedical Co., Ltd.RecruitingHepatocellular CarcinomaKorea, Republic of
-
Exact Sciences CorporationRecruitingHepatitis B | Hepatocellular Carcinoma | Cirrhosis | Liver Cancer | Hepatocellular CancerUnited States
-
Boston Scientific CorporationBiocompatibles UK LtdRecruitingHepatocellular CarcinomaUnited States, Spain, France
-
Guangxi Medical UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingHepatocellular CarcinomaChina
-
Sichuan UniversityNot yet recruitingCarrelizumab Plus Lenvatinib Combined With TACE | Borderline Resectable Hepatocellular CarcinomaChina